EVAL
LIVE

Serial Number

98650106

Owner

EVAL Health LLC

First Use Date

Jul 1, 2024

Filing Date

Jul 16, 2024

Add to watchlist:

No watchlists yet
View on USPTO

EVAL Trademark

Serial Number: 98650106 • Registration: 8182847

EVAL is a trademark filed by EVAL Health LLC on July 16, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

EVAL Health LLC (2 trademarks)

6505 Glen Road
Saint Paul, MN 55129

Entity Type: 16

Trademark Details

Filing Date

July 16, 2024

Registration Date

March 24, 2026

First Use Anywhere

July 1, 2024

First Use in Commerce

July 1, 2024

Published for Opposition

February 3, 2026

Goods & Services

Platform as a service (PaaS) featuring HIPAA-compliant software platforms using artificial intelligence and machine learning, designed for healthcare providers to translate peer-reviewed medical research into low-code clinical apps and clinical decision support tools for use at the point of care; Software as a service (SaaS) services featuring secure, regulatory-compliant, web-based and mobile software for low-code clinical apps, enabling clinicians and healthcare organizations to evaluate medical conditions, recommend evidence-based treatments, and implement published medical guidelines, all derived from standardized clinical research data

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 24, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 13, 2026 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 2, 2026 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 1, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 1, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jul 1, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 1, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 19, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 1, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
May 1, 2025 GNSL
SUSPENSION LETTER WRITTEN
May 1, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2025 CRFA
ASSIGNED TO LIE
May 1, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 17, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 11, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 11, 2025 GNSL
SUSPENSION LETTER WRITTEN
Apr 11, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 9, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 6, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 6, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 6, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 6, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 5, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 5, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 16, 2024 MAFR
NEW APPLICATION ENTERED
Jul 16, 2024 NWAP